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rntra-chain and inter-chain disuhide bonds within the ~rboxy-te~inal pro~ptides of human type I procoi- 
Iagen were studied using cyanogen bromide cleavage of the propeptides and electrophoresis on SDS-poly- 
acrylamide/glycerol gels. The results could provide a better understanding of the assembly of proa-chains 
into procollagen. 
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1. INTRODUCTION 
Type I procollagen consists of two praul(I)- 
chains and one procu2(1)-chain. The amino- 
terminal end contains a globular domain in which 
intra-chain dir&fide bonds exist, whereas no 
disulfides are found in the long triple helical do- 
main. The carboxy-terminal domain features both 
intra-chain and inter-chain disulfide bonds [l-4]. 
About half of the total of 23 cysteine residues 
found in the carboxy-terminal propeptides form 
inter-chain disulfides linking the three chains 
together [5]. 
The assembly of procu-chains into procollagen is 
thought to begin in the c~boxy-terming propep- 
tides by disulfide bond formation [1,3]. The rate 
limiting step seems to be the &s/tram- 
isomerization of the peptide bonds [6,7]. The 
carboxy-terminal disulfides may enhance triple 
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helix formation by serving as a nucleation site in 
that the three procu-chains are in order alignment 
for correct triple helix folding [8]. 
The primary structure of the human procul(I)- 
chain and procu2(1)-chain have recently been 
deduced by cDNA sequencing [9,10]. Human 
pr~l~I)~h~n contains a c~boxy-ter~n~ pro- 
peptide (Cl) consisting of 244 amino acids, eight 
of which are cysteine residues at positions 40, 46, 
63, 72, 80, 151, 195 and 242 [9]. The carboxy- 
terminal propeptide of the human prw2(1)-chain 
(C2) consists of 247 amino acids, the seven cysteine 
residues being at positions 44, 67, 76, 84, 153, 198 
and 245 [lo]. There is a high degree of homology 
between propeptides Cl and C2 in the locations of 
the cysteine residues, except for the fact that cys- 
teine residue 46 in Cl is missing in C2. 
It is not exactly known how the disulfide bonds 
are arranged within the carboxy-terminal propep- 
tides. Olsen [l l] concludes by cyanogen bromide 
(CNBr) peptide mapping experiments that two 
intra-chain disulfides lie between the residues 
80-242 and 151-195 in the Cl-propeptide, while 
Kuhn [8] proposes on theoretical grounds that 
inter-chain disulfides may lie between residues 
40-46 and 44-46, linking the two Cl-propeptides 
and the CZpropeptide together. 
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In this study CNBr fragments of isolated human 
type I carboxy-terminal propeptides were pro- 
duced from native propeptides, propeptides con- 
taining only intra-chain disulfides and totally 
reduced propeptides. Peptide maps of these CNBr 
fragments were then used to resolve the disulfide 
bonds of the propeptide chains. 
2. EXPERIMENTAL 
Iodinated carboxy-terminal propeptides of 
human type I procollagen were kindly donated by 
Dr Juha Risteli, Department of Medical 
Biochemistry, University of Oulu, Finland [ 121. 
The radiolabeled material was reduced totally by 
10 mM DTT or partially by 0.5 mM DTT, which 
is known to reduce only inter-chain disulfides [5]. 
Free cysteine residues were blocked by adding 
iodoacetic acid to a final concentration of 0.1 M. 
The DTT and iodoacetic acid were removed by 
centrifugation in Sephadex G-25 gels [ 131. 
The unreduced, partially reduced and totally 
reduced propeptides were digested with CNBr at 
room temperature for 24 h in 70% formic acid, 
after which they were lyophilized and submitted to 
electrophoresis on SDS-polyacrylamide/glycerol 
gels as described in [ 141. After drying, the gels were 
exposed to Kodak X-Omat films to identify the 
radiolabeled propeptides and/or fragments of 
these. The films were scanned by densitometry. 
All theoretically possible CNBr-derived 
fragments of unreduced, partially reduced or total- 
ly reduced carboxy-terminal propeptides were 
deduced from the primary sequence of human 
prml(I) and proa2(1) carboxy-propeptides and 
then from different possibilities for inter-chain and 
intra-chain pairing of cysteine residues within 
these. The experimental results were compared to 
theoretical possibilities to resolve how the disulfide 
bonds lie within the carboxy-terminal propeptide 
of human type I procollagen. 
3. RESULTS AND DISCUSSION 
The SDS-polyacrylamide/glycerol slab gels used 
[14] showed an overall resolution of peptides with 
molecular masses between 2 and 100 kDa. The Rf 
value versus logarithm of molecular mass was 
linear within this range (fig.1). No confusing 
broadening of bands of low molecular mass was 
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Fig. 1. Standards used for determination of the 
molecular masses of propeptide and its CNBr fragments 
on SDS-polyacrylamide/glycerol gels. Standards (k&) 
were phosphorylase b (92500), bovine serum albumin 
(bsa, 66200), ovalbumin (45000), pepsin (35000), soya 
bean trypsin inhibitor (sbti, 21500), cytochrome c 
(11700), insulin (5800) and the b-chain of insulin (3400). 
seen, and peptides differing by only about 500 Da 
could be separated by this method. 
The unreduced radiolabeled carboxy-terminal 
propeptide of human type I procollagen seemed to 
be of 100 kDa, which fits in well with the value ex- 
pected, in view of the fact that propeptides 
prepared in the manner followed here contain 
some amino acids belonging to the telopeptide 
region [ 121. This unreduced material also appeared 
to contain dimeric and monomeric propeptides 
with an apparent molecular mass of 64 and 
34 kDa, respectively (fig.3D). 
Theoretically, eleven different peptide frag- 
ments are obtained by CNBr digestion of totally 
reduced propeptides (fig.2). Peptides I-VI are 
gained from the Cl propeptide and peptides 
VII-XI from C2. When totally reduced radiolabel- 
ed propeptides were digested with CNBr only three 
bands were seen on the slab gels (fig.3A), with ap- 
parent molecular masses of 4.3, 3.5 and 2.8 kDa. 
The theoretical calculations suggest that the 
4.3 kDa fragment could be peptide III, the 
3.5 kDa fragment peptide II and the 2.8 kDa frag- 
ment peptide V (see fig.2). The molecular mass of 
peptide V is as calculated from the amino acid 
composition 2.1 kDa, but this contains a car- 
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Fig.2. Schematic representation of the carboxy-terminal 
propeptides of the human type I prml(I)-chain (Cl) and 
procu2(1)-chain (C2). The vertical bars indicate the 
positions of methionine residues and the dots the 
positions of cysteine residues. CNBr fragments of the 
propeptides are marked by Roman numerals I-XI and 
their theoretical molecular masses given in kDa. Cho = 
carbohydrate moiety. 
bohydrate moiety in the asparagine residue at posi- 
tion 146, which would give it a higher molecular 
mass [9]. The other peptides were not labeled 
because the radioiodination was not complete, 
although all the peptides except peptide IX contain 
tyrosine residues capable of being iodinated. 
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Fig.3. Scanning curves for (A) totally reduced 
propeptide after CNBr digestion, (B) partly reduced 
propeptide after CNBr digestion, and (C) unreduced 
propeptide after CNBr digestion, (D) unreduced, 
undigested propeptide. The numbers indicate the 
following molecular mass (in kDa): 1,44; 2, 16.6; 3,4.3; 
4, 3.5; 5, 2.8. T, trimeric propeptide; D, dimeric 
propeptide; M, monomers of the propeptide. 
After partial reduction with 0.5 mM DTT, 
which is capable of reducing only inter-chain 
disulfide bonds, an additional band with a 
molecular mass of 16.6 kDa occurred (fig.3B) and 
the proportions of the 4.3 and 2.8 kDa bands 
diminished. This new fragment must thus contain 
peptides III + V+ VI, indicating that there are 
intra-chain disulfides between residues 80-242 and 
151-195 in the Cl propeptide (fig.4). 
In order to resolve the inter-chain disulfides be- 
tween the propeptides, umeduced propeptides 
were cleaved by CNBr. Slab gels now showed two 
additional bands with apparent molecular masses 
of 44 and 16.6 kDa (fig.3C) as compared with the 
unreduced, undigested material (fig.3D). The 
16.6 kDa fragment was theoretically assumed to be 
composed of CNBr peptides III + V+VI and the 
44 kDa fragment could have been composed only 
of peptides I + II + II + VII + VIII + X + XI, in- 
dicating that the inter-chain disulfide bonds lie be- 
tween residues 40-46, 44-46, 63-72, 67-72 and 
63-76 (fig.4). 
Since the unreduced material also contained 
monomeric and dimeric propeptides (fig.3D), the 
cyanogen bromide peptides derived from these 
should be noted. In fact, the 16.6 and 3.5 kDa pep- 
tides seen in fig.3C are probably obtained from the 
C 1 propeptide, while from dimers consisting of the 
Cl + C2, peptides II + VII + VIII + X + XI and 
III + V + VI corresponding to molecular masses of 
33.2 and 16.6 kDa should be seen. The former 





Fig.4. Schematic representation of disulfides in 
propeptides (A) and fragments after digestion of 
unreduced propeptides by CNBr (B), showing the 44 and 
16.6 kDa fragments. 
231 
Volume 212, number 2 FEBS LETTERS February 1987 
and are seen in the region of the monomer-sized 
protein. Dimers consisting of two Cl propeptides 
give fragments 2x (I+ II) and III+ V+VI and 
yield an additional band of 23.2 kDa (the faint 
band between the monomers and the 16.6 kDa 
fragment in fig.3C). 
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